Plasma annexin A5, anti-annexin A5 antibodies and annexin A5 polymorphism in Egyptian female patients with systemic lupus erythematosus and antiphospholipid syndrome

Clinical Laboratory

Volumn 60, Issue 1, 2014, Pages 133-137

  Nasef, Aya ^a   Ibrahim, Mona ^a   Riad, Nermine ^a   Mousa, Somaia Mohammed ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Annexin A5; Annexin A5 ( 1C T) polymorphism; Antiphospholipid syndrome; Recurrent pregnancy loss; Systemic lupus erythematosus

Indexed keywords

ANNEXIN A5; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 84893908940     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.130112     Document Type: Article

References (27)

1. Rand JH. Molecular pathogenesis of the antiphospholipid syndrome. Circ Res 2002;11:29-37. (Pubitemid 34074605)
2. Rand JH, Wu XX, Quinn AS, et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol 2003;163:1193-200. (Pubitemid 37040155)
3. Reutelingsperger CPM. Annexins: key regulators of haemostasis, thrombosis and apoptosis. Thromb Haemost 2001,86:413-9. (Pubitemid 32663970)
4. Gerke V, Moss SE. Annexins: From Structure to Function. Physiol Rev 2002;82:331-71. (Pubitemid 34654456)
5. Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Ikeda Y. Clinical significance of anti-ANV antibodies in patients with systemic lupus erythematosus. Am J Hematol 1997;54:209-13. (Pubitemid 27148259)
6. Ogawa H, Zhao D, Dlott JS, et al. Elevated anti-ANV antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities. Am J Clin Pathol 2000;114:619-28. (Pubitemid 33044402)
7. Rodriguez-Garcia MI, Fernandez JA, Rodriguez A, et al. ANV auto antibodies in rheumatoid arthritis. Ann Rheum Dis 1996;55(12):895-900. (Pubitemid 26426683)
8. El Serougy IM, Shahin AA, Soliman DA, Akhnoukh AF, Mousa SM. Clinical significance of serum anti-annexin V antibodies in Egyptian patients with scleroderma. Egypt J Immunol 2009;16(1):1-8.
9. Gaspersic N, Rot U, Cucnik S, Kveder T, Bozic B, Rozman B. Antiannexin V antibodies in patients with cerebrovascular disease. Ann Rheum Dis 2003;62:188-9. (Pubitemid 36135403)
10. Nojima J, Kuratsune H, Suehisa E, et al. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 2001;47:1008-15. (Pubitemid 32493585)
11. Arnold J, Holmes Z, Pickering W, Farmer C, Regan L, Cohen H. Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. Br J Haematol 2001;113:911-4. (Pubitemid 32634758)
12. Gris JC, Quere I, Sanmarco M, et al. Antiphospholipid and antiprotein syndromes in non-thrombotic, nonautoimmune women with unexplained recurrent primary early foetal loss. The Nimes Obstetricians and Haematologists Study NOHA. Thromb Haemost 2000;84:228-36. (Pubitemid 30601468)
13. Cookson BT, Engelhardt S, Smith C, Bamford HA, Prochazka M, Tait JF. Organization of the human annexin V (ANX5) gene. Genomics 1994;20:463-7. (Pubitemid 24130730)
14. González-Conejero R, Corral J, Roldán V, et al. A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients. Blood 2002;15;100(6):2081-6.
15. Van Heerde WL, Reutelingsperger CP, Maassen C, Lux P, Derksen RH, de Groot PG. The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasma. J Thromb Haemost 2003;1:532-6.
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7. (Pubitemid 13221242)
17. de Laat B, Derksen RH, Mackie I J, et al. Annexin A5 polymorphism (-1C->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. Ann Rheum Dis 2006;65(11):1468-72. (Pubitemid 44629124)
18. Tripathy NK, Sinha N, Nityanand S. Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity. Clin Exp Immunol 2003;134(2):360-4. (Pubitemid 37372290)
19. Hrycek A, Cieślik P. Annexin A5 and anti-annexin antibodies in patients with systemic lupus erythematosus. Rheumatol Int 2012;32(5):1335-42.
20. Franchi F, Viscardi Y, Cetin I, Bucciarelli P, Martinelli I, Biguzzi E. Annexin V C/T-1 polymorphism and pregnancy complications. Haematologica 2006;91(6):864. (Pubitemid 44014565)
21. Szodoray P, Tarr T, Tumpek J, et al. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Autoimmunity 2009;42(6):497-506.
22. Satoh A, Suzuki K, Takayama E, et al. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 1999;26(8):1715-20. (Pubitemid 29367310)
23. Becarevic M, Singh S, Majkic-Singh N. Oxidized LDL, anti-oxidized LDL and anti-annexin A5 antibodies in primary antiphospholipid syndrome. Clin Lab 2008;54(3-4):97-101. (Pubitemid 351954196)
24. Zammiti W, Mtiraoui N, Kallel C, Mercier E, Almawi WY, Mahjoub T. A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against beta2-glycoprotein I and annexin V. Reproduction 2006;131(4):817-22.
25. Sater MS, Finan RR, Mustafa FE, Al-Khateeb GM, Almawi WY. Anti-annexin V IgM and IgG autoantibodies and the risk of idiopathic recurrent spontaneous miscarriage. Reprod Immunol 2011;89(1):78-83.
26. Alijotas-Reig J, Ferrer-Oliveras R, Rodrigo-Anoro MJ, et al. Anti-annexin A5 antibodies in women with spontaneous pregnancy loss. Med Clin (Barc) 2010;134(10):433-8.
27. Bizzaro N, Antico A, Musso M, et al. A prospective study of 1038 pregnancies on the predictive value of anti-annexin V antibodies for fetal loss. Ann N Y Acad Sci 2005;1050:348-56. (Pubitemid 41129453)